These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8244417)

  • 1. Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptide.
    Robinson RG; Rapp L; Bowdish KJ; Graham MA; Huff AC; Coughlin SA
    Hybridoma; 1993 Aug; 12(4):407-15. PubMed ID: 8244417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
    Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
    Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes.
    Negri C; Chiesa R; Cerino A; Bestagno M; Sala C; Zini N; Maraldi NM; Astaldi Ricotti GC
    Exp Cell Res; 1992 Jun; 200(2):452-9. PubMed ID: 1315288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase II beta: stability and distribution in different animal cells in comparison to DNA topoisomerase I and II alpha.
    Negri C; Scovassi AI; Braghetti A; Guano F; Astaldi Ricotti GC
    Exp Cell Res; 1993 May; 206(1):128-33. PubMed ID: 7683276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human topoisomerase II alpha in cell lines and tissues: characterization of five novel monoclonal antibodies.
    Kellner U; Heidebrecht HJ; Rudolph P; Biersack H; Buck F; Dakowski T; Wacker HH; Domanowski M; Seidel A; Westergaard O; Parwaresch R
    J Histochem Cytochem; 1997 Feb; 45(2):251-63. PubMed ID: 9016314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
    Meliconi R; Bestagno M; Sturani C; Negri C; Galavotti V; Sala C; Facchini A; Ciarrocchi G; Gasbarrini G; Astaldi Ricotti GC
    Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled-coil template.
    Helmke SM; Lu SM; Harmon M; Glasford JW; Larsen TD; Kwok SC; Hodges RS; Perryman MB
    J Mol Recognit; 2006; 19(3):215-26. PubMed ID: 16680721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality characterization of natural epitope-specific antibodies against the tumor-related antigen topoisomerase IIa by peptide chip and proteome analysis: a pilot study with colorectal carcinoma patient samples.
    Linnebacher M; Lorenz P; Koy C; Jahnke A; Born N; Steinbeck F; Wollbold J; Latzkow T; Thiesen HJ; Glocker MO
    Anal Bioanal Chem; 2012 Apr; 403(1):227-38. PubMed ID: 22349330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope distribution of randomly established monoclonal antibodies against human type II DNA topoisomerases.
    Sakaguchi A; Miyaike M; Kuroda K; Nozaki N; Tanaka M; Hibino M; Fujii Y; Kato S; Kikuchi A
    J Biochem; 2002 Sep; 132(3):409-16. PubMed ID: 12204110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.
    Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM
    Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation, epitope analysis and clinical application of monoclonal antibodies against heart-type fatty acid binding protein].
    Han Q; Cong S; Yi W; Chen S; Liang W; Chen A; Hu C; Li S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):620-4. PubMed ID: 23746246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor.
    Ali S; Lutz Y; Bellocq JP; Chenard-Neu MP; Rouyer N; Metzger D
    Hybridoma; 1993 Aug; 12(4):391-405. PubMed ID: 7503939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a novel monoclonal antibody specific to peptide VEHVVADAGAFLRH.
    Cao J
    Hybridoma (Larchmt); 2009 Feb; 28(1):59-62. PubMed ID: 19207013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New monoclonal antibodies recognizing p53 protein phosphorylated by casein kinase II at serine 392.
    Pospísilová S; Kanková K; Svitáková M; Nenutil R; Vojtesek B
    Folia Biol (Praha); 2001; 47(4):148-51. PubMed ID: 11508859
    [No Abstract]   [Full Text] [Related]  

  • 15. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
    Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DNA topoisomerases in chronic proliferative kidney disease.
    Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
    Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FNIII domain D of human tenascin-C.
    Fan QY
    Hybridoma (Larchmt); 2010 Feb; 29(1):84. PubMed ID: 20199166
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic peptide-generated monoclonal antibodies to transforming growth factor-beta 1.
    Tahara N; Yasumitsu H; Umeda M
    Hybridoma; 1993 Aug; 12(4):441-53. PubMed ID: 7503942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of the MPM-2 phosphoepitope.
    Ding M; Feng Y; Vandré DD
    Exp Cell Res; 1997 Feb; 231(1):3-13. PubMed ID: 9056407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.